ICD112K ;ALB/MJF - YEARLY DRG UPDATE; October 01, 2020@15:42
;;18.0;DRG Grouper;**112**;October 20, 2000;Build 8
;
; Updates for DRGS 810-999
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^0.9388^2.5
;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.3903^3.6
;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.8980^2.7
;;813^16^MED^COAGULATION DISORDERS^1.5651^3.6
;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^1.8791^4.6
;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^1.0311^3.0
;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.7290^2.2
;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^3.1298^3.7
;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.5901^3.6
;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.8885^1.6
;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.3176^10.3
;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.1624^3.4
;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.2050^1.6
;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.3264^9.9
;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.2903^5.1
;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.3166^2.3
;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^5.1419^9.4
;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.4347^4.3
;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.7391^2.6
;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.1647^5.9
;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4705^2.2
;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.1948^3.4
;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7005^2.5
;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5040^1.9
;;834^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC^5.5300^9.4
;;835^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC^2.0971^4.3
;;836^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.5688^2.8
;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^5.3822^11.2
;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.2241^5.3
;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.3747^4.5
;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.1070^6.6
;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.5948^4.0
;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.1037^2.6
;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.9374^5.4
;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1406^3.5
;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8455^2.5
;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.4090^5.7
;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.2181^3.6
;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.9291^2.7
;;849^17^MED^RADIOTHERAPY^2.3389^6.4
;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9010^9.6
;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^2.0556^5.1
;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.5277^3.2
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.4127^9.0
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1090^5.3
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.4146^3.5
;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8291^5.0
;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^1.0059^3.4
;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8482^2.6
;;865^18^MED^VIRAL ILLNESS WITH MCC^1.6728^4.2
;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8997^2.8
;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.1134^5.5
;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0557^3.5
;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7408^2.5
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.7909^13.2
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9572^5.0
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0280^3.5
;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.1963^6.2
;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9062^2.7
;;881^19^MED^DEPRESSIVE NEUROSES^0.8555^3.9
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.8735^3.3
;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.6145^5.2
;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.5700^4.7
;;885^19^MED^PSYCHOSES^1.2955^6.2
;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.3650^4.6
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.2965^3.3
;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5718^2.0
;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.5587^8.4
;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7556^5.0
;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8513^3.3
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.3986^9.1
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.9818^4.7
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.2156^2.7
;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.5519^6.7
;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.5599^3.1
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.7878^2.9
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.8657^6.8
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.0565^3.8
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3647^2.3
;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.5141^3.9
;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.8891^2.4
;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.8201^3.8
;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6642^1.8
;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.5225^3.6
;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8177^2.4
;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.7936^4.3
;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0218^2.9
;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.7279^2.1
;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.5558^4.1
;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^0.9432^2.8
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^18.9822^23.3
;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.1913^12.1
;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^2.9388^6.1
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^3.0330^2.3
;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^1.8760^4.5
;;935^22^MED^NON-EXTENSIVE BURNS^2.0241^3.7
;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.0971^6.1
;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.2033^3.2
;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.8874^2.0
;;945^23^MED^REHABILITATION WITH CC/MCC^1.5052^4.4
;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1226^3.1
;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2156^3.5
;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.7776^2.5
;;949^23^MED^AFTERCARE WITH CC/MCC^1.1920^4.9
;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.7095^3.3
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.5692^1.8
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.7360^8.1
;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8042^6.1
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.4105^9.7
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.1705^6.6
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.5687^3.8
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7732^5.3
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.4645^3.9
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9099^2.5
;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^7.2476^13.2
;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^3.0884^6.2
;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.8730^6.9
;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.3757^4.2
;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.9228^3.3
;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.2999^3.6
;;981^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.5804^8.5
;;982^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.5082^4.3
;;983^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6702^2.1
;;987^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.3184^7.8
;;988^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.6964^4.2
;;989^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1024^2.1
;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
;;999^99^**^UNGROUPABLE^0.0^0.0
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD112K 10664 printed Oct 16, 2024@17:48:04 Page 2
ICD112K ;ALB/MJF - YEARLY DRG UPDATE; October 01, 2020@15:42
+1 ;;18.0;DRG Grouper;**112**;October 20, 2000;Build 8
+2 ;
+3 ; Updates for DRGS 810-999
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^0.9388^2.5
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.3903^3.6
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.8980^2.7
+4 ;;813^16^MED^COAGULATION DISORDERS^1.5651^3.6
+5 ;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^1.8791^4.6
+6 ;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^1.0311^3.0
+7 ;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.7290^2.2
+8 ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^3.1298^3.7
+9 ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.5901^3.6
+10 ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.8885^1.6
+11 ;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.3176^10.3
+12 ;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.1624^3.4
+13 ;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.2050^1.6
+14 ;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.3264^9.9
+15 ;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.2903^5.1
+16 ;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.3166^2.3
+17 ;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^5.1419^9.4
+18 ;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.4347^4.3
+19 ;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.7391^2.6
+20 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.1647^5.9
+21 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4705^2.2
+22 ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.1948^3.4
+23 ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7005^2.5
+24 ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5040^1.9
+25 ;;834^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC^5.5300^9.4
+26 ;;835^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC^2.0971^4.3
+27 ;;836^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.5688^2.8
+28 ;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^5.3822^11.2
+29 ;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.2241^5.3
+30 ;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.3747^4.5
+31 ;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.1070^6.6
+32 ;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.5948^4.0
+33 ;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.1037^2.6
+34 ;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.9374^5.4
+35 ;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1406^3.5
+36 ;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8455^2.5
+37 ;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.4090^5.7
+38 ;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.2181^3.6
+39 ;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.9291^2.7
+40 ;;849^17^MED^RADIOTHERAPY^2.3389^6.4
+41 ;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9010^9.6
+42 ;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^2.0556^5.1
+43 ;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.5277^3.2
+44 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.4127^9.0
+45 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1090^5.3
+46 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.4146^3.5
+47 ;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8291^5.0
+48 ;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^1.0059^3.4
+49 ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8482^2.6
+50 ;;865^18^MED^VIRAL ILLNESS WITH MCC^1.6728^4.2
+51 ;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8997^2.8
+52 ;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.1134^5.5
+53 ;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0557^3.5
+54 ;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7408^2.5
+55 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.7909^13.2
+56 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9572^5.0
+57 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0280^3.5
+58 ;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.1963^6.2
+59 ;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9062^2.7
+60 ;;881^19^MED^DEPRESSIVE NEUROSES^0.8555^3.9
+61 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.8735^3.3
+62 ;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.6145^5.2
+63 ;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.5700^4.7
+64 ;;885^19^MED^PSYCHOSES^1.2955^6.2
+65 ;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.3650^4.6
+66 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.2965^3.3
+67 ;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5718^2.0
+68 ;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.5587^8.4
+69 ;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7556^5.0
+70 ;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8513^3.3
+71 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.3986^9.1
+72 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.9818^4.7
+73 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.2156^2.7
+74 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.5519^6.7
+75 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.5599^3.1
+76 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.7878^2.9
+77 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.8657^6.8
+78 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.0565^3.8
+79 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3647^2.3
+80 ;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.5141^3.9
+81 ;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.8891^2.4
+82 ;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.8201^3.8
+83 ;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6642^1.8
+84 ;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.5225^3.6
+85 ;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8177^2.4
+86 ;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.7936^4.3
+87 ;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0218^2.9
+88 ;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.7279^2.1
+89 ;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.5558^4.1
+90 ;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^0.9432^2.8
+91 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^18.9822^23.3
+92 ;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.1913^12.1
+93 ;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^2.9388^6.1
+94 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^3.0330^2.3
+95 ;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^1.8760^4.5
+96 ;;935^22^MED^NON-EXTENSIVE BURNS^2.0241^3.7
+97 ;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.0971^6.1
+98 ;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.2033^3.2
+99 ;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.8874^2.0
+100 ;;945^23^MED^REHABILITATION WITH CC/MCC^1.5052^4.4
+101 ;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1226^3.1
+102 ;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2156^3.5
+103 ;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.7776^2.5
+104 ;;949^23^MED^AFTERCARE WITH CC/MCC^1.1920^4.9
+105 ;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.7095^3.3
+106 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.5692^1.8
+107 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.7360^8.1
+108 ;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8042^6.1
+109 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.4105^9.7
+110 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.1705^6.6
+111 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.5687^3.8
+112 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7732^5.3
+113 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.4645^3.9
+114 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9099^2.5
+115 ;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^7.2476^13.2
+116 ;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^3.0884^6.2
+117 ;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.8730^6.9
+118 ;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.3757^4.2
+119 ;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.9228^3.3
+120 ;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.2999^3.6
+121 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.5804^8.5
+122 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.5082^4.3
+123 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6702^2.1
+124 ;;987^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.3184^7.8
+125 ;;988^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.6964^4.2
+126 ;;989^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1024^2.1
+127 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
+128 ;;999^99^**^UNGROUPABLE^0.0^0.0
+129 ;;EXIT
